Insider selling
Traded Nov 19 · filed the same day
A Bridgebio Pharma officer told the SEC about a plan to sell $2.34M of Bridgebio Pharma shares around Nov 19, 2026. The shares were not acquired as compensation. That is a tiny part of all Bridgebio Pharma shares.